600080.SHG Ginwa Enterprise Group Inc

Healthcare Pharmaceuticals Shanghai Stock Exchange
4.00 CNY
Close of Nov 5, 2026
3.79 9.35
Market cap
CNY 1.49B
P/E
-
P/B
0.94x
ROE
-3.0%
Dividend yield
0.90%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600080.SHG undervalued?

Graham number

The Graham number of Ginwa Enterprise Group Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ginwa Enterprise Group Inc fundamental analysis

No fundamental analysis for Ginwa Enterprise Group Inc yet.

Ginwa Enterprise Group Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ginwa Enterprise Group Inc

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is …

Full company profile